Sensitivity TP/TP+FN [95% CI] Specificity TN/FP+TN [95% CI] PPV TP/TP+FP [95% CI] NPV TN/FN+TN [95% CI]
PRIMARY ENDPOINT(S) FebriDx Viral vs. Case Definition (Viral-all) 97.2% 35/36 [85.5-99.9] 100% 12/12 [73.5-100] 100% 35/35 [90.0-100] 92.3% 12/13 [64.0-99.8]
FebriDx Viral vs. Case Definition (COVID-19 Viral) 100% 35/35 [90-100] 100% 13/13 [75.3-100] 100% 35/35 [90-100] 100% 13/13 [75.3-100]
SECONDARY ENDPOINT Initial SARS-CoV-2 rRT-PCR vs. Case Definition (COVID-19 Viral) 82.9% 29/35 [66.4-93.4] 100% 13/13 [75.3-100] 100% 29/29 [88.1-100] 68.4% 13/19 [43.4-87.4]
ADDITIONAL ENDPOINT FebriDx Bacterial vs. Case Definition (Bacterial) 100% 8/8 [63.1-100] 92.5% 37/40 [79.6-98.4] 72.7% 8/11 [39.0-94.0] 100% 37/37 [90.5-100.0]